US 10376582
Buffer formulations for enhanced antibody stability
granted A61KA61K39/39591A61K47/02
Quick answer
US patent 10376582 (Buffer formulations for enhanced antibody stability) held by Outlook Therapeutics, Inc. expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Outlook Therapeutics, Inc.
- Grant date
- Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 82
- CPC classes
- A61K, A61K39/39591, A61K47/02, A61K47/12, A61K47/26